BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
-12.68%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.45B
AUM Growth
+$2.45B
(-17%)
Cap. Flow
+$113M
Cap. Flow
% of AUM
4.62%
Top 10 Holdings %
Top 10 Hldgs %
73.47%
Holding
55
New
2
Increased
12
Reduced
5
Closed
4
Top Buys
| 1 |
Ionis Pharmaceuticals
IONS
|
$57.7M |
| 2 |
Axsome Therapeutics
AXSM
|
$35.2M |
| 3 |
Kura Oncology
KURA
|
$34.2M |
| 4 |
Protagonist Therapeutics
PTGX
|
$32.6M |
| 5 |
Revolution Medicines
RVMD
|
$28.3M |
Top Sells
| 1 |
Agios Pharmaceuticals
AGIO
|
$35.3M |
| 2 |
89bio
ETNB
|
$33.9M |
| 3 |
GH Research
GHRS
|
$17.3M |
| 4 |
enGene Holdings
ENGN
|
$14M |
| 5 |
Xoma
XOMA
|
$13M |
Sector Composition
| 1 | Healthcare | 99.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
NLS Pharmaceutics
NLSP
$9.96M
| $221K | 0.01% |
143,676
| – | – |
|
|
52
89bio
ETNB
$1.37B
| – | – |
-4,333,885
| Closed | -$33.9M |
|
|
53
enGene Holdings
ENGN
$249M
| – | – |
-2,106,037
| Closed | -$14M |
|
|
ELEV
54
DELISTED
Elevation Oncology
ELEV
| – | – |
-2,966,836
| Closed | -$1.67M |
|
|
55
Agios Pharmaceuticals
AGIO
$2.36B
| – | – |
-1,073,755
| Closed | -$35.3M |
|